The Withings BPM Pro 2, a blood pressure monitor that uses cellular technology, has received FDA clearance. Withings states that this device is the first of its kind, enabling remote monitoring for healthcare providers.
Launch and Features
The BPM Pro 2 was introduced in October when the company announced it was pursuing FDA clearance prior to the device's launch. It's important to mention that Withings is still waiting for FDA approval for its 1-lead ECG, which will help detect atrial fibrillation, and is expected to be available in 2025. The BPM Pro 2 allows patients to check their diastolic and systolic blood pressure along with their pulse rate from the comfort of their homes. Additionally, there are Patient Insights questionnaires to provide context to the data, and the device can prompt users to retake measurements when necessary.
Availability and Pricing
Healthcare professionals can now purchase the Withings BPM Pro 2, although the exact price has not been disclosed. In other updates, Withings has announced that the BPM Pro 2 has been recognized as a CES 2025 Innovation Awards Honoree in the Digital Health category. For those in need of a consumer-grade blood pressure monitor, Withings has the BPM Connect available, which is currently priced at $90.32 on Amazon.
Recognition and Other Products
Withings continues to expand its range of smart health devices, focusing on user-friendly technology for better health management. The BPM Pro 2 stands out among its offerings, demonstrating the company's commitment to innovation in health monitoring.
Source: Link
